Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Receivables - Other: 2024

Historic Receivables - Other for Centessa Pharmaceuticals (CNTA) over the last 1 years, with Dec 2024 value amounting to $287,000.

  • Centessa Pharmaceuticals' Receivables - Other was N/A to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $287,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Centessa Pharmaceuticals' Receivables - Other is $287,000.
  • In the past 5 years, Centessa Pharmaceuticals' Receivables - Other registered a high of $287,000 during FY2024, and its lowest value of $287,000 during FY2024.
  • For the 1-year period, Centessa Pharmaceuticals' Receivables - Other averaged around $287,000, with its median value being $287,000 (2024).